Registry Following People With Atrial Fibrillation in Shanghai
Records people with atrial fibrillation in Shanghai to study their care and outcomes.
Plain-language title generated from the registry record
Registry title: Shanghai Atrial Fibrillation Registry
Key facts
- Where
- Shanghai, ChinaSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for Shanghai residents with atrial fibrillation (AF) confirmed by ECG or Holter monitoring since 2015, who have government health insurance.
- Sex
- Men and women can join.
- Disease stage
- Atrial fibrillation (AF) diagnosed since 2015, confirmed by a 12-lead ECG or Holter monitoring.
Main reasons for not taking part
- Not a resident of Shanghai
- No government-issued health insurance
- Died on the day AF was first diagnosed
Read by machine on 9 November 2026.
Where in China
- Xinhua Hospital, School of Medicine, Shanghai Jiao Tong UniversityShanghai, ChinaNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
- Trial code
- NCT06802965
- Record updated
- 31 January 2025
- Original description
Using the Shanghai Municipal Health Commission database and Shanghai Centers for Disease Control and Prevention database, patients with AF in Shanghai are included to construct the Shanghai AF registry to investigate clinical characteristics, treatment, and prognosis.Read full original descriptionShow less
Shanghai Atrial Fibrillation Registry
Using the Shanghai Municipal Health Commission database and Shanghai Centers for Disease Control and Prevention database, patients with AF in Shanghai are included to construct the Shanghai AF registry to investigate clinical characteristics, treatment, and prognosis.
Inclusion: With diagnosis of AF: the diagnosis must be identified from the Shanghai Municipal Health Commission database and verified by 12-lead ECG or Holter monitoring since 2015; Residents of Shanghai; Taking part in the government-issued health insurance, including the Urban Residents' Basic Medical Insurance (URBMI), the Urban-Employ Based Medical Insurance (UEBMI) and the New Rural Cooperative Medical Scheme (NRCMS).
Exclusion: Non-residence of Shanghai; Without the government-issued health insurance; Die at the day of index diagnosis of AF.